Biotechnology IPOs

2 Biotechnology IPOs have come to market (2016–2025), raising a combined ₹3,806 crore. They have averaged a +29.8% listing gain (median +31.5%), and 100% closed their debut above the issue price. The strongest debut was Advanced Enzyme Technologies Limited (+31.5%); the weakest was Anthem Biosciences Limited (+28.1%).